A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance

Parasitology

Volumn 115, Issue 3, 1997, Pages 223-230

  Wang, P ^a   Sims, P F G ^a   Hyde, J E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Dihydropteroate synthetase; Fansidar resistance; Folate; Malaria; Plasmodium falciparum; Sulfadoxine

Indexed keywords

4 AMINOBENZOIC ACID; DIHYDROPTEROATE SYNTHASE; FANSIDAR; FOLIC ACID; SULFADOXINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; MALARIA FALCIPARUM; NONHUMAN; PARASITE CULTIVATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; DNA, PROTOZOAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG RESISTANCE; ERYTHROCYTES; FOLIC ACID; HUMANS; HYPOXANTHINE; PARASITOLOGY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PYRIMETHAMINE; REPRODUCIBILITY OF RESULTS; SULFADOXINE;

PLASMODIUM FALCIPARUM;

EID: 0030868588     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182097001431     Document Type: Article

References (20)

1. ASAHI, H., KANAZAWA, T., KAJIHARA, Y., TAKAHASHI, K. & TAKAHASHI, T. (1996). Hypoxanthine - a low-molecular-weight factor essential for growth of erythrocytic Plasmodium falciparum in a serum-free medium. Parasitology 113, 19-23.
2. BLOLAND, P. B., LACKRITZ, E. M., KAZEMBE, P. N., WERE, J. B. O., STEKETEE, R. & CAMPBELL, C. C. (1993). Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficiency and treatment policy in Africa. Journal of Infectious Diseases 167, 932-937.
3. BROOKS, D. R., WANG, P., READ, M., WATKINS, W. M., SIMS, P. F. G. & HYDE, J. E. (1994). Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. European Journal of Biochemistry 224, 397-405.
4. CHANARIN, I. (1980). The folates. In Vitamins in Medicine, Vol. 1 (ed. Barker, B. M. & Bender, D. A.), pp. 247-314. Heinemann Medical Books, London.
5. 3H]hypoxanthine incorporation. Experimental Parasitology 55, 138-146.
6. CHULAY, J. D., WATKINS, W. M. & SIXSMITH, D. G. (1984). Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene 33, 325-330.
7. MILHOUS, W. K., WEATHERLY, N. F., BOWDRE, J. H. & DESJARDINS, R. E. (1985). In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrobial Agents and Chemotherapy 27, 525-530.
8. NGUYEN-DINH, P., PANE, D., TEKLEHAIMANOT, A., ZEVALLOS-IPENZA, A., DAY, M. M. & DUVERSEAU, Y. T. (1985). Development of an in vitro microtest for determining the susceptibility of Plasmodium falciparum to sulfadoxine-pyrimethamine: laboratory investigations and field studies in Port-au-Prince, Haiti. Bulletin of the World Health Organization 63, 585-592.
9. READ, M. & HYDE, J. E. (1993). Simple in vitro cultivation of the malaria parasite Plasmodium falciparum (erythrocytic stages) suitable for large-scale preparations. In Protocols in Molecular Parasitology (ed. Hyde, J. E.), pp. 43-56. Humana Press, New Jersey.
10. REEDER, J. C., RIECKMANN, K. H., GENTON, B., LORRY, K., WINES, B. & COWMAN, A. F. (1996). Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. American Journal of Tropical Medicine and Hygiene 55, 209-213.
11. ROLLO, I. M. (1955). The mode of action of sulphonamides, proguanil and pyrimethamine on Plasmodium gallinaceum. British Journal of Pharmacology 10, 208-214.
12. SCHAPIRA, A., BYGBJERG, I. C., JEPSEN, S., FLACHS, H. & BENTZON, M. W. (1986). The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine - correlation of in vivo and in vitro results. American Journal of Tropical Medicine and Hygiene 35, 239-245.
13. SPENCER, H. C., WATKINS, W. M., SIXSMITH, D. G., KOECH, D. K. & CHULAY, J. D. (1984). A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya. Bulletin of the World Health Organization 62, 615-621.
14. TAN-ARIYA, P., BROCKELMAN, C. R. & MENABANDHU, C. (1987). Optimal concentrations of p-aminobenzoic acid and folic acid in the in vitro assay of antifolates against Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 37, 42-48.
15. TRIGLIA, T. & COWMAN, A. F. (1994). Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences, USA 91, 7149-7153.
16. VAN HENSBROEK, M. B., MORRIS-JONES, S., MEISNER, S., JAFFAR, S., BAYO, L., DACKOUR, R., PHILLIPS, C. & GREENWOOD, B. M. (1995). Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 672-676.
17. WANG, P., BROOKS, D. R., SIMS, P. F. G. & HYDE, J. E. (1995). A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Molecular and Biochemical Parasitology 71, 115-125.
18. WANG, P., READ, M., SIMS, P. F. G. & HYDE, J. E. (1997). Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilisation. Molecular Microbiology 23, 979-986.
19. WATKINS, W. M., SIXSMITH, D. G., CHULAY, J. D. & SPENCER, H. C. (1985). Antagonism of sulfadoxine and pyrimethamine antimalarial activities in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Molecular and Biochemical Parasitology 14, 55-61.
20. WATKINS, W. M., HOWELLS, R. E., BRANDLING-BENNETT, A. D. & KOECH, D. K. (1987). In vitro susceptibility of Plasmodium falciparum isolates from Jilore, Kenya to antimalarial drugs. American Journal of Tropical Medicine and Hygiene 37, 445-451.